FRM
Fox Run Management’s ResMed RMD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-3,950
| Closed | -$903K | – | 1177 |
|
2024
Q4 | $903K | Buy |
+3,950
| New | +$903K | 0.16% | 194 |
|
2024
Q3 | – | Sell |
-8,347
| Closed | -$1.6M | – | 1056 |
|
2024
Q2 | $1.6M | Buy |
8,347
+4,408
| +112% | +$844K | 0.3% | 56 |
|
2024
Q1 | $780K | Buy |
+3,939
| New | +$780K | 0.17% | 220 |
|
2023
Q3 | – | Sell |
-3,035
| Closed | -$663K | – | 946 |
|
2023
Q2 | $663K | Buy |
+3,035
| New | +$663K | 0.19% | 202 |
|
2023
Q1 | – | Sell |
-3,148
| Closed | -$655K | – | 895 |
|
2022
Q4 | $655K | Buy |
+3,148
| New | +$655K | 0.26% | 88 |
|
2022
Q1 | – | Sell |
-2,083
| Closed | -$543K | – | 668 |
|
2021
Q4 | $543K | Buy |
+2,083
| New | +$543K | 0.32% | 70 |
|
2021
Q1 | – | Sell |
-1,026
| Closed | -$218K | – | 297 |
|
2020
Q4 | $218K | Buy |
+1,026
| New | +$218K | 0.44% | 123 |
|
2018
Q3 | – | Sell |
-5,370
| Closed | -$556K | – | 784 |
|
2018
Q2 | $556K | Buy |
+5,370
| New | +$556K | 0.18% | 195 |
|
2017
Q4 | – | Sell |
-6,900
| Closed | -$531K | – | 854 |
|
2017
Q3 | $531K | Buy |
+6,900
| New | +$531K | 0.15% | 272 |
|
2017
Q2 | – | Sell |
-7,900
| Closed | -$569K | – | 792 |
|
2017
Q1 | $569K | Buy |
7,900
+1,300
| +20% | +$93.6K | 0.23% | 143 |
|
2016
Q4 | $410K | Buy |
+6,600
| New | +$410K | 0.22% | 190 |
|